
Shares of telehealth platform Hims & Hers HIMS.N fall 2.3% to $46.03 premarket
Late on Thursday, Bloomberg News reported that the U.S. Federal Trade Commission is investigating Hims & Hers over its advertising and subscription cancellation practices, citing people familiar with the matter
A spokesperson for HIMS was not immediately available for comment outside of regular business hours
Stock up ~95% YTD